In future, immune PET imaging may be used to characterise CD8 T cell/APC migration, for example between tumour and secondary immune organs (typically the site where professional antigen-presenting dendritic cells interact most productively with T cells), and activation status over time, following an immune intervention such as ICI. Here, CD8A is linked to neoplasm.